Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ventyx Biosciences
Biotech
Sanofi makes $27M equity investment in Ventyx
Ventyx has received a $27 million boost from Sanofi in exchange for negotiation rights to a phase 2 asset being studied in obesity and Parkinson's.
Gabrielle Masson
Sep 23, 2024 11:24am
Ventyx's last hope for inflammatory med ends in Crohn's failure
Jul 29, 2024 9:45am
Atai, Eli Lilly, Novartis & more—Chutes & Ladders
May 17, 2024 8:30am
Former FDA leader Woodcock inspires Biotech Sisterhood summit
Apr 24, 2024 9:23am
Ventyx lays off 20% of staff after cutting TYK2 indications
Dec 8, 2023 8:45am
Ventyx stock drops 70% as TYK2 inhibitor psoriasis plans halted
Nov 7, 2023 7:23am
